Clinical Trials

Clinical trials are research studies that test whether new medical treatments, devices or strategies  are safe and effective.

People who volunteer for clinical trials play an active role in their own health care, often gain access to experimental treatments, and help others by improving and advancing medical care.

At Providence Cancer Center, our scientists and physicians work closely together to make clinical trials a regular part of cancer care. Patients may take part in studies initiated by our translational researchers at the Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute, in addition to studies sponsored by the National Cancer Institute or pharmaceutical and biotechnology companies.

Our clinical trials team works directly with physicians to identify clinical trials appropriate for their patients’ specific stage of disease.

The goals of clinical research vary from trial to trial. Generally, they are designed to:

  • Improve prevention, early diagnosis and treatment of cancer
  • Discover whether a particular drug  or medical treatment is safe and effective
  • Advance the state of scientific and medical knowledge
  • Measure and improve the quality of life for patients and their families
Find cancer clinical trials available in Oregon in the list below. You may search by keyword or condition/disease, or browse using the page numbers and arrows. Find additional trials by using the search term “Oncology Multiple Tumor Sites". To learn more about a particular trial and qualification criteria, click the trial name and then the listed contact link, or talk with your physician.

For more information about clinical trials available through Providence Cancer Center, call 503-215-6014
« Previous 12345 Next »
Viewing Page 1 of 26 | Showing Results 1 - 5 of 130

A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer.

This randomized phase III trial studies how well duloxetine hydrochloride works compared to a placebo in treating muscle, bone, and joint pain in...

Kelly Perlewitz MD
  • California
  • Clackamas Radiation Oncology Center
  • Oncology and Hematology Care Southeast
  • Pacific Cancer Research Consortium (PCRC)
  • Providence Milwaukie Hospital
  • Providence Newberg Medical Center
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
  • Providence Willamette Falls Medical Center

An Observational Cohort Study of Treatment Patterns and Outcomes in Patients with HER2 Positive (HER2+) Metastatic Breast Cancer

This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+)...

Alison Conlin MD
  • Oncology and Hematology Care Eastside
  • Oncology and Hematology Care Newberg
  • Oncology and Hematology Care Southeast
  • Oncology and Hematology Care Westside

A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients With Metastatic Breast Cancer

This randomized phase III trial is studying early surgery to see how well it works compared to standard palliative therapy in treating patients...

Keith Lanier MD
  • California
  • Clackamas Radiation Oncology Center
  • Pacific Cancer Research Consortium (PCRC)
  • Providence Milwaukie Hospital
  • Providence Newberg Medical Center
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
  • Providence Willamette Falls Medical Center

A Randomized Phase III Trial Evaluating the Role of Axillary Lymph Node Dissection in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

This randomized phase III trial studies axillary lymph node dissection to see how well it works compared to axillary radiation therapy in treating...

Keith Lanier MD
  • California
  • Clackamas Radiation Oncology Center
  • Pacific Cancer Research Consortium (PCRC)
  • Providence Milwaukie Hospital
  • Providence Newberg Medical Center
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
  • Providence Willamette Falls Medical Center

A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer

This is a two arm Phase III trial in first- and second-line HER2 negative patients with locally recurrent or metastatic breast cancer. The primary...

Alison Conlin MD
  • Oncology and Hematology Care Eastside
  • Oncology and Hematology Care Newberg
  • Oncology and Hematology Care Southeast
  • Oncology and Hematology Care Westside
  • Oncology and Hematology Care Willamette Falls
« Previous 12345 Next »
Viewing Page 1 of 26 | Showing Results 1 - 5 of 130